Home › Eli Lilly: The Blockbuster Combination Of Elanco And Novartis' Animal Health
 

Keywords :   


Eli Lilly: The Blockbuster Combination Of Elanco And Novartis' Animal Health

2015-01-03 11:18:31| Biotech - Topix.net

Elanco has been recently authorized by the FTC to take over Novartis' Animal Health segment, along with a condition to sell off Novartis' Sentinel product line. This combination will raise Eli Lilly's global market rank to number 2 in the animal pharmaceutical market in terms of total revenue, following Zoetis, which has topped the list.

Tags: health combination animal eli

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05China's Nio unveils Tesla Model Y rival
16.05Could the US economy be doing too well?
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05The man who turned his dead father into a chatbot
16.05Firms leaving UK 'not a crisis' says stock market boss
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
More »